Current Studies

HPV Protocols Protocol Title
AMC-045 Phase II Trial Of Combined Modality Therapy Plus Cetuximab in HIV-Associated Anal Carcinoma
AMC-054 (India) A Single-Arm, Open-Label Pilot Study of the Safety and Immunogenicity of the Merck Quadrivalent Human Papillomavirus Vaccine among HIV-Positive Women in India
AMC-058 A Companion Protocol To Evaluate Anogenital Human Papillomavirus (HPV) Infection And Anogenital Squamous Intraepithelial Lesions (ASIL) In Patients Participating In AMC Clinical Trials
AMC-072 Protective Effect of quadrivalent vaccine in young HIV-positive males who have sex with males
AMC-076 A Randomized Clinical Trial of Infrared Coagulation (IRC) Ablation versus Expectant Management of Intra-Anal High Grade Intraepithelial Neoplasia (HGAIN) in HIV-infected Subjects
KS Protocols Protocol Title
AMC-050 (Brazil) Pilot Study of Liposomal Daunorubicin Citrate in Patients With HIV-Related Kaposi's Sarcoma
AMC-059Phase I/II Trial of Anti-VEGF Small Molecule PTC299 in Patients With HIV-Related Kaposi's Sarcoma
AMC-063 Single-arm, dose-finding pilot trial of single-agent bortezomib in patients with relapsed/refractory AIDS-associated Kaposi sarcoma with correlative assessments of KSHV and HIV
AMC-070 A Phase I/II Study of Lenalidomide in Patients with AIDS-Associated Kaposi’s Sarcoma
Lymphoma Protocols Protocol Title
AMC-053 Safety and Efficacy Pilot Trial of the Anti-Viral and Anti-Tumor Activity of Velcade Combined with (R)ICE in Subjects with EBV and/or HHV-8 positive Relapsed/Refractory AIDS-Associated Non-Hodgkin’s Lymphoma
AMC-071 High Dose Chemotherapy with Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients
AMC-073 Phase II Study of Response-Adapted Therapy Using Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy Comprising ABVD With Versus Without Combination Chemotherapy Comprising Standard or Escalated BEACOPP in Patients with Stage III-IV Hodgkin Lymphoma
AMC-075 A Sequential Phase I/Randomized Phase II Trial of Vorinostat and Risk-Adapted Chemotherapy with Rituximab in HIV-Related B-cell Non-Hodgkin’s Lymphoma
NADC Protocols Protocol Title
AMC-061 A Phase I/Pharmacokinetic Study of Sunitinib in Patients with Cancer who also have HIV and are on HAART Therapy
Lab Protocols Protocol Title
AMC-064 Evaluation of Clonal Ig DNA in Plasma from Patients with Aggressive B-cell Lymphomas